Ohio catheter device company PercuVision gets FDA approval

PercuVision logoCOLUMBUS, Ohio — PercuVision, which has developed a device that guides medical staff through a urethral catheterizations, has received U.S. Food & Drug Administration clearance to market its device.

The company built its DirectVision System to be a “visual guide” through the urethra that will cut down on problematic insertions into the urethra and cut health-care costs by eliminating costly procedures from catheter-related damage. The $29,000 device is essentially a catheter with a fiber-optic flashlight and camera at the end. Nurses, who usually perform catheter insertions, can see the catheter’s path and will be more likely to complete the procedure smoothly and quickly the first time, according to PercuVision.

The company raised $2.9 million in preparation for the approval and is continuing to raise capital. It plans to double its eight member workforce and will immediately start selling in Ohio and neighboring states.

Reblog this post [with Zemanta]
Chris Seper

Chris Seper MedCity News

Chris Seper is the CEO and editor in chief at MedCity Media, which publishes MedCityNews.com. Reach him at chris@medcitynews.com.

more

Comments RSS Post a comment

No comments yet.

Post a Comment

Submit Comment

Be a Thought Leader: Join MedCitizens

Anyone can blog on MedCity News when they become a "MedCitizen." MedCitizens publish their own thoughts about current medical news and the latest issues in healthcare to the entire MedCity News audience.

Click to login or learn more

MedCity Twitter Buzz

MedCity Jobs Board

Real Time Web Analytics